ENTITY
J.B. Chemicals & Pharmaceuticals

J.B. Chemicals & Pharmaceuticals (JBCP IN)

30
Analysis
Health CareIndia
J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.
more
Refresh
15 Nov 2021 17:02Broker

Industry beating growth in India drives Q2

JB Chemicals & Pharmaceuticals’ (JBCPL) Q2FY22 performance was better than estimates driven by strong growth in India business. EBITDA margin was...

Share
12 Jul 2020 07:57

Last Week In Event SPACE: FamilyMart, Sina, Line Corp, Metlifecare, Accordia Golf, Jingjeng, O-Net

Last Week in Event SPACE ... Interestingly, the impact of FamilyMart Co Ltd (8028 JP)'s shareholder dynamic on price may not be what "smart"...

Logo
462 Views
Share
05 Jul 2020 16:00

J.B.Chemicals (JBCP IN): Partial Tender Offer by KKR

The Promoters of J.B. Chemicals & Pharma (JBCP IN)announced on 3rd July they had signed an SPA with KKR & Co Inc (KKR US) to sell up to 54%...

Share
07 Dec 2018 20:49

JB Chemicals - 2QFY19 – No Significant Surprises; On Track for Continuing Growth

J.B. Chemicals & Pharma (JBCP IN) 2QFY19 results were in line with our estimates. The revenues were Rs 4,043 mn, 1% higher than our estimates...

Logo
461 Views
Share
13 Oct 2018 19:39

Coverage Universe 2QFY19E Earnings Preview

The 2QFY19E earnings season carries huge importance as the FY19 is turning out to be a year of sharp volatility in performance across all the...

Logo
420 Views
Share
x